-
‘California’ brand insulin is hitting the market
14 Dec 2025 12:03 GMT
… on insulin, the lifesaving medication for people living with diabetes, for … large, for-profit pharmaceutical companies.
Producing the insulin is Civica Rx … drug market.
Drug companies followed suit. The new CalRx insulin is interchangeable with Lantus …
-
3 Common Medications That Don’t Mix Well With Cinnamon
08 Dec 2025 17:39 GMT
… your blood clots.
2. Diabetes Medications and Insulin
Diabetes medications, which are used to … sitagliptin)
Insulin, such as Novolog or Lantus
Other non-insulin, injectable medications such … take a statin medicine for your cholesterol, or other drugs that may …
-
<![CDATA[The Expanding Role of Biologics in Treatment for Metabolic Syndrome]]>
05 Dec 2025 03:46 GMT
… syndrome, traditional pharmaceuticals, such as metformin and statin drugs, “laid the … long-acting Lantus in 2000. Three insulin biosimilars are … add-on glucose-lowering medication was lower with … when added to existing diabetes treatment, according to a 2021 …
-
Rising type 1 diabetes in Indian children sparks urgent health concerns
28 Nov 2025 03:29 GMT
… the right medication, a knowledgeable doctor who understands type 1 diabetes, and … Diabetes Federation
CHALLENGES FACED BY PATIENTS
>> Basic treatment using insulin … drugs enter the National Essential Medicines List, prices drop — for example, Lantus …
-
Massy Distribution sale on pause pending decision on insulin
27 Nov 2025 14:07 GMT
… more than 30 subsidised insulin products for diabetic users. The Humulin … Distribution Jamaica distributes Apidra, Lantus and Novolin which are manufactured … . Seprod Ltd controls Facey Pharmaceuticals, Jamaica’s second largest …
-
FTC delays Massy Distribution sale over insulin dominance
26 Nov 2025 10:28 GMT
… insulin distribution by both companies. Insulin is mainly used in the treatment of diabetes … manufactured by Novo Nordisk while Lantus and Apidra are manufactured by … doctors as well.
However, it was noted that Jamaica’s largest pharmaceutical …
-
Studies from Touro College of Pharmacy in the Area of Biologics Reported (Assessing the Value of Biosimilars: A Cost-Effectiveness Approach for Managed Care Organizations): Biotechnology – Biologics
19 Nov 2025 01:50 GMT
… -- Data detailed on Biotechnology - Biologics have been … (CD), and Type 1 Diabetes Mellitus (DM)-using biologic … (Cyltezo), Infliximab (Avsola), and Insulin Glargine (Semglee). We aim to … maintaining patient access and treatment outcomes. A formulary review …
-
EU Clears Path for Biosimilars in Diabetes & Bone Health
17 Nov 2025 15:41 GMT
… meeting, the European Medicines Agency’s (EMA) … diseases: Ondibta (insulin glargine, Gan & Lee Pharmaceuticals Europe GmbH) … to the reference product Lantus SoloStar (Sanofi), authorized … is intended for the treatment of diabetes in adults, adolescents …
-
Human medicines European public assessment report (EPAR): Ondibta, insulin glargine, Status: Opinion
14 Nov 2025 15:28 GMT
… the medicinal product Ondibta, intended for the treatment of diabetes mellitus. …
The applicant for this medicinal product is Gan & Lee Pharmaceuticals … to Lantus (insulin glargine).
The full indication is:
Treatment of diabetes mellitus …
-
Otsuka's HAE med Dawnzera, Lilly's oral SERD Inluriyo among drugs scoring EU endorsements
15 Nov 2025 00:57 GMT
… FDA’s finish line, Ionis Pharmaceuticals’ RNA-targeted hereditary angioedema (HAE) treatment … that showed the drug was associated … diabetes infusion Teizeild, which was classified under CHMP’s priority medicine … s long-acting insulin Lantus and Theramex Ireland …